tetano
Editor, Senior Moderator
ASAIO J
. 2021 Mar 1;67(3):245-249.
doi: 10.1097/MAT.0000000000001376.
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Crisis Standards of Care
Cara Agerstrand[SUP] 1 [/SUP], Richard Dubois[SUP] 2 [/SUP], Koji Takeda[SUP] 3 [/SUP], Nir Uriel[SUP] 4 [/SUP], Philippe Lemaitre[SUP] 3 [/SUP], Justin Fried[SUP] 4 [/SUP], Amirali Masoumi[SUP] 4 [/SUP], Eva W Cheung[SUP] 5 [/SUP], Yuji Kaku[SUP] 3 [/SUP], Lucas Witer[SUP] 3 [/SUP], Peter Liou[SUP] 2 [/SUP], Claire Gerall[SUP] 6 [/SUP], Rafael Klein-Cloud[SUP] 6 [/SUP], Darryl Abrams[SUP] 1 [/SUP], Jennifer Cunningham[SUP] 1 [/SUP], Purnema Madahar[SUP] 1 [/SUP], Madhavi Parekh[SUP] 1 [/SUP], Briana Short[SUP] 1 [/SUP], Natalie H Yip[SUP] 1 [/SUP], Alexis Serra[SUP] 1 [/SUP], James Beck[SUP] 7 [/SUP], Michael Brewer[SUP] 7 [/SUP], Kenmund Fung[SUP] 7 [/SUP], Dana Mullin[SUP] 7 [/SUP], Roy Oommen[SUP] 3 [/SUP], Bryan Payne Stanifer[SUP] 3 [/SUP], William Middlesworth[SUP] 6 [/SUP], Joshua Sonett[SUP] 3 [/SUP], Daniel Brodie[SUP] 1 [/SUP]
Affiliations
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has placed extraordinary strain on global healthcare systems. Use of extracorporeal membrane oxygenation (ECMO) for patients with severe respiratory or cardiac failure attributed to COVID-19 has been debated due to uncertain survival benefit and the resources required to safely deliver ECMO support. We retrospectively investigated adult patients supported with ECMO for COVID-19 at our institution during the first 80 days following New York City's declaration of a state of emergency. The primary objective was to evaluate survival outcomes in patients supported with ECMO for COVID-19 and describe the programmatic adaptations made in response to pandemic-related crisis conditions. Twenty-two patients with COVID-19 were placed on ECMO during the study period. Median age was 52 years and 18 (81.8%) were male. Twenty-one patients (95.4%) had severe ARDS and seven (31.8%) had cardiac failure. Fifteen patients (68.1%) were managed with venovenous ECMO while 7 (31.8%) required arterial support. Twelve patients (54.5%) were transported on ECMO from external institutions. Twelve patients were discharged alive from the hospital (54.5%). Extracorporeal membrane oxygenation was used successfully in patients with respiratory and cardiac failure due to COVID-19. The continued use of ECMO, including ECMO transport, during crisis conditions was possible even at the height of the COVID-19 pandemic.
. 2021 Mar 1;67(3):245-249.
doi: 10.1097/MAT.0000000000001376.
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Crisis Standards of Care
Cara Agerstrand[SUP] 1 [/SUP], Richard Dubois[SUP] 2 [/SUP], Koji Takeda[SUP] 3 [/SUP], Nir Uriel[SUP] 4 [/SUP], Philippe Lemaitre[SUP] 3 [/SUP], Justin Fried[SUP] 4 [/SUP], Amirali Masoumi[SUP] 4 [/SUP], Eva W Cheung[SUP] 5 [/SUP], Yuji Kaku[SUP] 3 [/SUP], Lucas Witer[SUP] 3 [/SUP], Peter Liou[SUP] 2 [/SUP], Claire Gerall[SUP] 6 [/SUP], Rafael Klein-Cloud[SUP] 6 [/SUP], Darryl Abrams[SUP] 1 [/SUP], Jennifer Cunningham[SUP] 1 [/SUP], Purnema Madahar[SUP] 1 [/SUP], Madhavi Parekh[SUP] 1 [/SUP], Briana Short[SUP] 1 [/SUP], Natalie H Yip[SUP] 1 [/SUP], Alexis Serra[SUP] 1 [/SUP], James Beck[SUP] 7 [/SUP], Michael Brewer[SUP] 7 [/SUP], Kenmund Fung[SUP] 7 [/SUP], Dana Mullin[SUP] 7 [/SUP], Roy Oommen[SUP] 3 [/SUP], Bryan Payne Stanifer[SUP] 3 [/SUP], William Middlesworth[SUP] 6 [/SUP], Joshua Sonett[SUP] 3 [/SUP], Daniel Brodie[SUP] 1 [/SUP]
Affiliations
- PMID: 33627596
- DOI: 10.1097/MAT.0000000000001376
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has placed extraordinary strain on global healthcare systems. Use of extracorporeal membrane oxygenation (ECMO) for patients with severe respiratory or cardiac failure attributed to COVID-19 has been debated due to uncertain survival benefit and the resources required to safely deliver ECMO support. We retrospectively investigated adult patients supported with ECMO for COVID-19 at our institution during the first 80 days following New York City's declaration of a state of emergency. The primary objective was to evaluate survival outcomes in patients supported with ECMO for COVID-19 and describe the programmatic adaptations made in response to pandemic-related crisis conditions. Twenty-two patients with COVID-19 were placed on ECMO during the study period. Median age was 52 years and 18 (81.8%) were male. Twenty-one patients (95.4%) had severe ARDS and seven (31.8%) had cardiac failure. Fifteen patients (68.1%) were managed with venovenous ECMO while 7 (31.8%) required arterial support. Twelve patients (54.5%) were transported on ECMO from external institutions. Twelve patients were discharged alive from the hospital (54.5%). Extracorporeal membrane oxygenation was used successfully in patients with respiratory and cardiac failure due to COVID-19. The continued use of ECMO, including ECMO transport, during crisis conditions was possible even at the height of the COVID-19 pandemic.